Effects Of Prednisolone On Rheumatoid Arthritis Patients

GlaxoSmithKline (GSK)

Status: Completed

Conditions: Arthritis, Rheumatoid

Study type: Observational

Funder types: Industry

Identifiers

NCT00330889

999920/040

Details and patient eligibility

About

This study will assess the Pharmacokinetic (PK) and Pharmacodynamic (PD) effects of Prednisolone on Rheumatoid Arthritis (RA) patients.

Enrollment: 32 patients

Sex: All

Ages: 25 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Meet the ACR criteria for diagnosis of rheumatoid arthritis.
• Required treatment with Prednisolone.
• Currently on a non-steroidal anti-inflammatory agent (NSAID).
• Willing to stay on current dose of NSAID for two weeks during study.

Exclusion criteria

• Major health issues such as osteoporosis, diabetes, heart failure, heart attack, kidney failure, or acute infection.